Pure Monograph

AI-powered pharma revolution: Optimize formulations, predict stability/anomalies, master tech transfer & CTD docs. Secure, compliant, unstoppable.

[Pure Monograph @PureMonograph]

A new era dawns with the AI-powered revolution! Unveiling next-gen pharma innovation that transforms healthcare. Stay ahead—transformation begins. #BiotexAi #AIinPharma #Innovation

[Kayhan Moayeri @__kayhan]

Pharm.D. and founder here — been building this at @PureMonograph for two years. CMC, CTD, tech transfer, BMRs, all machine-verifiable. But the deal-breaker isn't the documentation layer — it's pairing it with de novo molecule design. Discover the molecule and generate the submission-ready dossier in one system. That's the real OS for pharma.

[Kayhan Moayeri @__kayhan]

Building two vertical AI companies where generic AI gets people fired or sued.
@RegentForge: OCC/Fed/FDIC rules into audit-ready bank policies in hours. Not consultants. Hours.
@PureMonograph : pharma-native AI that works both ends of a drug program. Upstream: trial design benchmarked against real cohorts, counterfactual positioning, and forensic teardown of why trials fail. Downstream: full CMC documentation from a single molecule. Calibrated, not hallucinating — every PMID verified, confidence scored honestly.
One molecule in. Intelligence and work product out.

[Kayhan Moayeri @__kayhan]

@PureMonograph : pharma-native AI that works both ends of a drug program. Upstream: trial design benchmarked against real cohorts, counterfactual positioning, and forensic teardown of why trials fail. Downstream: full CMC documentation from a single molecule. Calibrated, not hallucinating — every PMID verified, confidence scored honestly.
One molecule in. Intelligence and work product out.

[Kayhan Moayeri @__kayhan]

Watching this live !! the future of work software is exactly the conversation that needs to happen right now.
We need infrastructure that holds up under real pressure for @PureMonograph and @RegentForge — pharma and fintech compliance don’t forgive unreliable tools.
Backed Fin before when I was running Plitio Pharmacy. Exited, built new, and came back. That says everything.

[Kayhan Moayeri @__kayhan]

Vancouver: Canada’s West Coast global tech powerhouse.

This week’s momentum: Serve Robotics’ sidewalk delivery pilot, three sovereign AI data centres, and new startups @RegentForge and @PureMonograph joining the ecosystem.

We’re building the future here. Proud to lead the charge.

[Kayhan Moayeri @__kayhan]

@RegentForge and @PureMonograph run dual-stack Claude + Grok verification.
o1 instant is fast. Our regulatory intel and pharma pipelines need reasoning depth + real-time synthesis Sonnet’s analysis with Grok’s speed. OpenAI’s good. Our stack’s built for domains where wrong answers cost millions.
Have you tested o1 instant on high-stakes verticals yet? Curious how it handles edge cases.

[Kayhan Moayeri @__kayhan]

Mark, Drug prices are high because drug development costs $2.5B and takes 10+ years. Most of that isn’t science. It’s process.
We built an AI platform that designs novel medicines from a disease target to a complete drug design brief in hours. Biology, PK, formulation, failure modes, regulatory pathway. All cited.
$199/month. Not $200K consulting engagements.
If you want drugs to be cheaper, make them cheaper to design. @PureMonograph
https://t.co/WF1ey93IuS

[Kayhan Moayeri @__kayhan]

CMC delay = $2M /month in lost revenue opportunity.

A 6-month documentation delay = $12M gone.

Not because of a clinical failure. Because documentation was slow.
@PureMonograph generates submission-ready CMC documents in hours. Your scientists review and approve. They don't write from scratch.
https://t.co/WF1ey93IuS

[Kayhan Moayeri @__kayhan]

We just shipped Price Benchmark.
No more guessing what your molecule should cost in Canada vs India vs UAE.
Real public data from 8+ countries. Traceable to source. Instant retail + tender + 4-tier CIF.
Market entry, global launch, tender response — all in one module.
Example: Paracetamol 500mg in Canada.
https://t.co/WF1ey93IuS
@PureMonograph

[Pure Monograph @PureMonograph]

Every patient is different. their medicine should be too.

Pure Monograph designs formulations around the patient — not the manufacturing line.

AI-driven. Scientist-validated. Regulator-ready.

https://t.co/QmmMTL6Qk2

#PersonalizedMedicine #PharmaAI #DrugDesign

[Kayhan Moayeri @__kayhan]

This is why we built @PureMonograph . Paul Conyngham took matters into his own hands when vets gave his dog Rosie just months to live. Using AI (including Grok), tumor sequencing, and collaboration with UNSW scientists, he helped design and deliver a personalized mRNA neoantigen cancer vaccine. Tumors shrank. Rosie is still fighting. Real-world personalized medicine — happening now. Read the full @Forbes story →

https://t.co/pPWUfDuoBu

[Pure Monograph @PureMonograph]

Inspired by Rosie, a dog who needed a personalized neoantigen cancer vaccine. No one had a monograph for that. Now anyone can build one.

https://t.co/QmmMTL6Qk2

[Kayhan Moayeri @__kayhan]

Describe a drug idea in plain English.
@PureMonograph covers 10 scientific dimensions — target biology, formulation, stability, PK, toxicity, manufacturing, regulatory compliance, IP, cost — and generates a complete submission-ready monograph.
In ~45 seconds.
Inspired by Rosie, a dog who needed a personalized neoantigen cancer vaccine. No one had a monograph for that. Now anyone can build one.

https://t.co/WF1ey93IuS

[Kayhan Moayeri @__kayhan]

Describe a drug idea in plain English.
@PureMonograph covers 10 scientific dimensions — target biology, formulation, stability, PK, toxicity, manufacturing, regulatory compliance, IP, cost — and generates a complete submission-ready monograph.
In ~45 seconds.
Inspired by Rosie, a dog who needed a personalized neoantigen cancer vaccine. No one had a monograph for that. Now anyone can build one.

https://t.co/WF1ey93IuS

[Pure Monograph @PureMonograph]

CTD dossiers. Tech Transfer. Formulation intelligence reports.Generated in minutes. Not months. @PureMonograph https://t.co/4LoxQbT86c

[Kayhan Moayeri @__kayhan]

18 months ago I started with nothing but 25 years of regulatory experience and two AI models.
Today I have two live platforms serving two heavily regulated industries:

@RegentForge (banking compliance)
@PureMonograph (pharma CMC & Tech Transfer)

Zero agency. $750/month total cost. Daily execution with Grok + Claude.
This is what solo founder + AI actually looks like in 2026.
Not theory. Not hype. Real products. Real revenue. Real distribution.
The old way is dead. The new way is just getting started.
Who else is building like this?

[Pure Monograph @PureMonograph]

CMC documentation has been stuck in 1998.We built the platform that fixes it.Pure Monograph — regulatory intelligence for the modern pharma scientist. https://t.co/QmmMTL6Qk2

[Pure Monograph @PureMonograph]

FDA just saw another rolling BLA submission today. Traditional CMC dossiers still take 14 months. Pure Monograph generates regulator-grade CTD output in 2–3 days. Speed matters. https://t.co/QmmMTL6Qk2

[Kayhan Moayeri @__kayhan]

True leadership isn’t about having all the answers, it’s about building a team that asks better questions, moves faster than the competition, and turns bold ideas into undeniable results. Stay curious, execute relentlessly, and never mistake activity for progress. @PureMonograph

[Pure Monograph @PureMonograph]

50–100× cheaper than incumbents. Not 10% cheaper. Not 30% cheaper.50 to 100 times cheaper. The math is not subtle. Pure Monograph. https://t.co/QmmMTL6Qk2 #CMC #PharmaAI

[Pure Monograph @PureMonograph]

$240B pharma services market.$2B+ CMC documentation subset. Pure Monograph is the only AI-native player.#CMC #PharmaAI #MarketOpportunity